These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


451 related items for PubMed ID: 3641694

  • 1. Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro.
    Mollnes TE, Ng YC, Peters DK, Lea T, Tschopp J, Harboe M.
    Clin Exp Immunol; 1986 Jul; 65(1):73-9. PubMed ID: 3641694
    [Abstract] [Full Text] [Related]

  • 2. C3 nephritic factor (C3NeF): dissociation of cell-bound and fluid phase stabilization of alternative pathway C3 convertase.
    Ng YC, Peters DK.
    Clin Exp Immunol; 1986 Aug; 65(2):450-7. PubMed ID: 3641695
    [Abstract] [Full Text] [Related]

  • 3. C3 nephritic factor stabilization of the classic C3 convertase: a role for C2 in C3 nephritic factor activity.
    McLean RH, Nilson SH.
    Proc Soc Exp Biol Med; 1979 Jul; 161(3):358-63. PubMed ID: 461464
    [No Abstract] [Full Text] [Related]

  • 4. Effect of decay-accelerating factor on the assembly of the classical and alternative pathway C3 convertases in the presence of C4 or C3 nephritic factor.
    Ito S, Tamura N, Fujita T.
    Immunology; 1989 Dec; 68(4):449-52. PubMed ID: 2481642
    [Abstract] [Full Text] [Related]

  • 5. [Complement and nephritic activity in membranoproliferative glomerulonephritis].
    Lévy M, Sich M, Habib R.
    Arch Fr Pediatr; 1979 Nov; 36(9 Suppl):LXIV-LXXIV. PubMed ID: 539879
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Activation of the classical complement pathway by nephritic factor bound to the alternative pathway C3/C5 convertase.
    Sobel AT, Cooper NR, Schreiber RD.
    J Immunol; 1979 Jan; 122(1):34-8. PubMed ID: 762421
    [Abstract] [Full Text] [Related]

  • 9. C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.
    Tanuma Y, Ohi H, Watanabe S, Seki M, Hatano M.
    Clin Exp Immunol; 1989 Apr; 76(1):82-5. PubMed ID: 2736802
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Production of nephritic factor of the alternative complement pathway by Epstein Barr virus-transformed B cell lines derived from a patient with membranoproliferative glomerulonephritis.
    Hiramatsu M, Balow JE, Tsokos GC.
    J Immunol; 1986 Jun 15; 136(12):4451-5. PubMed ID: 3011894
    [Abstract] [Full Text] [Related]

  • 13. Nephritic factor, C3 splitting activity, C3 and factor B breakdown products in glomerular diseases.
    De Vecchi A, Montagnino G, Scalia P, Tarantino A.
    Ric Clin Lab; 1980 Jun 15; 10(1):93-7. PubMed ID: 6781054
    [No Abstract] [Full Text] [Related]

  • 14. Current concepts in immunology: the alternative pathway of complement--a system for host resistance to microbial infection.
    Fearon DT, Austen KF.
    N Engl J Med; 1980 Jul 31; 303(5):259-63. PubMed ID: 6900901
    [No Abstract] [Full Text] [Related]

  • 15. [Progress in the knowledge of complement. II. Nephritic factors].
    Leibowitch J, Lesavre P.
    Nouv Presse Med; 1979 Jul 07; 8(30):2447-8. PubMed ID: 493036
    [No Abstract] [Full Text] [Related]

  • 16. [Partial lipodystrophy, hypocomplementemia and glomerulonephritis].
    Habib R, Lévy M, Gubler MC, Broyer M, Habib M.
    Arch Fr Pediatr; 1977 Jul 07; 34(7 Suppl):CXCVII-CCXII. PubMed ID: 931525
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Complement activation in acute glomerulonephritis in children.
    Levy M, Sich M, Pirotzky E, Habib R.
    Int J Pediatr Nephrol; 1985 Jul 07; 6(1):17-24. PubMed ID: 3997368
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Activation of the classical pathway of complement by the C3NeF-stabilized cell-bound amplification convertase.
    Daha MR, van Es LA.
    J Immunol; 1979 Mar 07; 122(3):801-5. PubMed ID: 448075
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.